S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Mesa Laboratories Stock Price, News & Analysis (NASDAQ:MLAB)

$220.62
+3.11 (+1.43 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$217.56
Now: $220.62
$221.74
50-Day Range
$210.93
MA: $228.44
$252.81
52-Week Range
$169.80
Now: $220.62
$268.47
Volume5,904 shs
Average Volume60,328 shs
Market Capitalization$961.46 million
P/E Ratio41.08
Dividend Yield0.29%
Beta0.26
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. Read More…

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
Current SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$103.14 million
Cash Flow$8.11 per share
Book Value$28.77 per share

Profitability

Net Income$7.48 million

Miscellaneous

Employees366
Market Cap$961.46 million
Next Earnings Date10/30/2019 (Estimated)
OptionableNot Optionable

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.


Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, October 1st. Investors of record on Friday, November 29th will be given a dividend of $0.16 per share on Monday, December 16th. This represents a $0.64 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Wednesday, November 27th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings results on Tuesday, July, 30th. The medical instruments supplier reported $1.73 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.59 by $0.14. The medical instruments supplier had revenue of $26.29 million for the quarter, compared to analyst estimates of $25.70 million. Mesa Laboratories had a return on equity of 19.67% and a net margin of 7.53%. View Mesa Laboratories' Earnings History.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for Mesa Laboratories.

What price target have analysts set for MLAB?

2 analysts have issued 1 year price objectives for Mesa Laboratories' stock. Their predictions range from $250.00 to $250.00. On average, they anticipate Mesa Laboratories' share price to reach $250.00 in the next year. This suggests a possible upside of 13.3% from the stock's current price. View Analyst Price Targets for Mesa Laboratories.

What is the consensus analysts' recommendation for Mesa Laboratories?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mesa Laboratories.

Has Mesa Laboratories been receiving favorable news coverage?

News articles about MLAB stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mesa Laboratories earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Mesa Laboratories.

Who are some of Mesa Laboratories' key competitors?

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Intel (INTC), Micron Technology (MU), Verizon Communications (VZ), Coupa Software (COUP), PepsiCo (PEP), Alibaba Group (BABA), Becton Dickinson and (BDX), Appian (APPN) and Crispr Therapeutics (CRSP).

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
  • Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
  • Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
  • Ms. Helene R. Leone, Gen. Counsel
  • Mr. Peter Jung, VP of Corp. Devel. & Strategy

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.09%), State of Alaska Department of Revenue (0.07%), Navellier & Associates Inc (0.03%) and NEXT Financial Group Inc (0.03%). Company insiders that own Mesa Laboratories stock include David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View Institutional Ownership Trends for Mesa Laboratories.

Which major investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Navellier & Associates Inc and NEXT Financial Group Inc. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Evan Guillemin, John Bradley Schmieder and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Which major investors are buying Mesa Laboratories stock?

MLAB stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue and Envestnet Asset Management Inc.. View Insider Buying and Selling for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $220.62.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $961.46 million and generates $103.14 million in revenue each year. The medical instruments supplier earns $7.48 million in net income (profit) each year or $5.37 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.View Additional Information About Mesa Laboratories.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is http://www.mesalabs.com/.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  188 (Vote Outperform)
Underperform Votes:  171 (Vote Underperform)
Total Votes:  359
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel